Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/42157
| Title: | CYP2C19 or CYP3A5 genotyping do not predict clinical response to clopidogrel | Authors: | Rodríguez-González, F. Martínez Quintana, Efrén Saavedra Santana, Pedro Medina-Gil, J. M. Riano, M. Garay-Sánchez, P. Tugores, A. |
UNESCO Clasification: | 32 Ciencias médicas | Keywords: | Aspirin Clopidogrel CYP2C19 CYP3A5 Diabetes, et al |
Issue Date: | 2018 | Publisher: | 1742-7835 | Journal: | Basic and Clinical Pharmacology and Toxicology | URI: | http://hdl.handle.net/10553/42157 | ISSN: | 1742-7835 | Source: | Basic and Clinical Pharmacology and Toxicology [ISSN 1742-7835], v. 123 (S2), p. 32 |
| Appears in Collections: | Actas de congresos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.